NORTH AMERICA VASCULAR STENTS MARKET FORECAST 2018-2026
KEY FINDINGS
The increase in the smoking and alcohol consumption habits has given rise to many cardiovascular and coronary diseases, which in turn is augmenting the demand for vascular stents in the North America region and growing the market to hit $9330 million by the end of the forecasting years.
MARKET INSIGHTS
The market for vascular stents is growing steadily in the region. In the year 2017, the market accounted for $4851 million. The growth of the market is expected at 7.69%. Furthermore, the market is also expected to continue the same trend in the coming years and contribute highest share to the overall vascular stents market. The United States and Canada are the two major countries of the North America region, and the U.S holds the largest revenue in the market.
COMPETITIVE INSIGHTS
The dominant players of the market are Terumo Corporation, Lombard Medical Technologies Inc., Microport Scientific Corporation, Translumina Gmbh, Abbott Laboratories, Braun Melsungen Ag, Endologix Inc., Meril Life Sciences Private Limited, Boston Scientific Corp., W.L. Gore and Associates, Inc. (U.S.), Biotronik Se & Co. Kg, Vascular Concepts Limited (India), and Medtronic Inc.
The increase in the smoking and alcohol consumption habits has given rise to many cardiovascular and coronary diseases, which in turn is augmenting the demand for vascular stents in the North America region and growing the market to hit $9330 million by the end of the forecasting years.
MARKET INSIGHTS
The market for vascular stents is growing steadily in the region. In the year 2017, the market accounted for $4851 million. The growth of the market is expected at 7.69%. Furthermore, the market is also expected to continue the same trend in the coming years and contribute highest share to the overall vascular stents market. The United States and Canada are the two major countries of the North America region, and the U.S holds the largest revenue in the market.
COMPETITIVE INSIGHTS
The dominant players of the market are Terumo Corporation, Lombard Medical Technologies Inc., Microport Scientific Corporation, Translumina Gmbh, Abbott Laboratories, Braun Melsungen Ag, Endologix Inc., Meril Life Sciences Private Limited, Boston Scientific Corp., W.L. Gore and Associates, Inc. (U.S.), Biotronik Se & Co. Kg, Vascular Concepts Limited (India), and Medtronic Inc.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. RISING INCIDENCE OF CARDIOVASCULAR DISORDERS
3.2.2. ADVANCES IN STENT TECHNOLOGY
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. INCIDENCE OF CARDIOVASCULAR DISEASES
4.1.2. DEMAND FOR MINIMALLY INVASIVE PROCEDURES
4.1.3. ACCEPTANCE OF VASCULAR STENTS
4.1.4. FAST DEVELOPMENT IN THE GERIATRIC POPULACE
4.2. RESTRAINTS
4.2.1. DIFFICULTIES OF VASCULAR STENTS
4.2.2. PRODUCT FIASCOS AND RECALLS
4.2.3. THREAT OF ALTERNATIVES
4.3. MARKET OPPORTUNITIES
4.3.1. IMPROVEMENT OF THE STENTS ELEMENTS
4.3.2. MANDATE FROM EMERGING MARKETS IS SWELLING
4.4. MARKET CHALLENGES
4.4.1. STRINGENT REGULATORY FRAMEWORK
4.4.2. INTENSE COMPETITION
5. MARKET SEGMENTATION
5.1. MARKET BY TYPES 2018-2026
5.1.1. DRUG-ELUTING STENTS
5.1.2. BARE-METAL STENTS
5.1.3. BIOABSORBABLE STENT
5.2. MARKET BY PRODUCTS 2018-2026
5.2.1. CORONARY STENTS
5.2.2. PERIPHERAL STENTS
5.2.2.1. CAROTID ARTERY STENTS
5.2.2.2. RENAL ARTERY STENTS
5.2.2.3. FEMORAL ARTERY STENTS
5.2.2.4. OTHER PERIPHERAL STENTS
5.2.3. EVAR STENT GRAFTS
5.2.3.1. ABDOMINAL AORTIC ANEURYSM STENTS
5.2.3.2. THORACIC AORTIC ANEURYSM STENTS
5.3. MARKET BY MODE OF DELIVERY 2018-2026
5.3.1. BALLOON-EXPANDABLE STENTS
5.3.2. SELF-EXPANDING STENTS
5.4. MARKET BY MATERIALS 2018-2026
5.4.1. METALLIC STENTS
5.4.1.1. COBALT CHROMIUM
5.4.1.2. PLATINUM CHROMIUM
5.4.1.3. NICKEL TITANIUM
5.4.1.4. STAINLESS STEEL
5.4.2. OTHER MATERIAL
5.5. MARKET BY END USERS 2018-2026
5.5.1. HOSPITALS AND CARDIAC CENTERS
5.5.2. AMBULATORY SURGICAL CENTERS
6. KEY ANALYTICS
6.1. PORTERS FIVE FORCES ANALYSIS
6.1.1. BARGAINING POWER OF BUYERS
6.1.2. BARGAINING POWER OF SUPPLIERS
6.1.3. THREAT OF NEW ENTRANTS
6.1.4. THREAT OF SUBSTITUTES
6.1.5. THREAT OF RIVALRY
6.2. KEY BUYING CRITERIA
6.3. REGULATORY FRAMEWORK
6.4. VALUE CHAIN ANALYSIS
6.5. MARKET TRENDS
6.5.1. INTRODUCTION OF NEW PRODUCTS RELATED TO VASCULAR STENTS
6.5.2. HYBRID PROCEDURES ARE RISING SIGNIFICANTLY
6.5.3. TECHNOLOGY ADVANCEMENTS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
8. COMPANY PROFILES
8.1. COMPETITIVE LANDSCAPE
8.1.1. MARKET ANALYSIS
8.2. ABBOTT LABORATORIES
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC INITIATIVE
8.3. BIOTRONIK SE & CO. KG
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SCOT ANALYSIS
8.4. BOSTON SCIENTIFIC CORP.
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. SCOT ANALYSIS
8.4.4. STRATEGIC INITIATIVE
8.5. BRAUN MELSUNGEN AG
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. SCOT ANALYSIS
8.5.4. STRATEGIC INITIATIVE
8.6. ENDOLOGIX INC
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.6.4. STRATEGIC INITIATIVES
8.7. LOMBARD MEDICAL TECHNOLOGIES INC.
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC INITIATIVES
8.8. MEDTRONIC INC.
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC INITIATIVE
8.9. MERIL LIFE SCIENCES PRIVATE LIMITED
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.10. MICROPORT SCIENTIFIC CORPORATION
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. SCOT ANALYSIS
8.10.4. STRATEGIC INITIATIVE
8.11. TERUMO CORPORATION
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. SCOT ANALYSIS
8.11.4. STRATEGIC INITIATIVE
8.12. TRANSLUMINA GMBH
8.12.1. COMPANY OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. SCOT ANALYSIS
8.13. VASCULAR CONCEPTS LIMITED (INDIA)
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. SCOT ANALYSIS
8.14. W.L. GORE AND ASSOCIATES, INC. (U.S.)
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. SCOT ANALYSIS
8.14.4. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 NORTH AMERICA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
TABLE 2 BENEFITS OF MINIMALLY INVASIVE SURGERY
TABLE 3 NORTH AMERICA VASCULAR STENTS MARKET, BY TYPE 2018-2026 ($ MILLION)
TABLE 4 NORTH AMERICA VASCULAR STENTS MARKET IN DRUG-ELUTING STENTS 2018-2026 ($ MILLION)
TABLE 5 NORTH AMERICA VASCULAR STENTS MARKET IN BARE-METAL STENTS 2018-2026 ($ MILLION)
TABLE 6 NORTH AMERICA VASCULAR STENTS MARKET IN BIOABSORBABLE STENT 2018-2026 ($ MILLION)
TABLE 7 NORTH AMERICA VASCULAR STENTS MARKET, BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 8 NORTH AMERICA VASCULAR STENTS MARKET IN CORONARY STENTS 2018-2026 ($ MILLION)
TABLE 9 NORTH AMERICA VASCULAR STENTS MARKET IN CORONARY STENTS 2018-2026 ($ MILLION)
TABLE 10 NORTH AMERICA VASCULAR STENTS MARKET IN PERIPHERAL STENTS 2018-2026 ($ MILLION)
TABLE 11 NORTH AMERICA VASCULAR STENTS MARKET IN PERIPHERAL STENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 12 NORTH AMERICA PERIPHERAL STENTS MARKET IN CAROTID ARTERY STENTS 2018-2026 ($ MILLION)
TABLE 13 NORTH AMERICA PERIPHERAL STENTS MARKET IN RENAL ARTERY STENTS 2018-2026 ($ MILLION)
TABLE 14 NORTH AMERICA PERIPHERAL STENTS MARKET IN FEMORAL ARTERY STENTS 2018-2026 ($ MILLION)
TABLE 15 NORTH AMERICA PERIPHERAL STENTS MARKET IN OTHER PERIPHERAL STENTS 2018-2026 ($ MILLION)
TABLE 16 NORTH AMERICA VASCULAR STENTS MARKET IN EVAR STENT GRAFTS 2018-2026 ($ MILLION)
TABLE 17 NORTH AMERICA VASCULAR STENTS MARKET IN EVAR STENT GRAFTS BY TYPES 2018-2026 ($ MILLION)
TABLE 18 NORTH AMERICA EVAR STENT GRAFTS MARKET IN ABDOMINAL AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
TABLE 19 NORTH AMERICA EVAR STENT GRAFTS MARKET IN THORACIC AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
TABLE 20 NORTH AMERICA VASCULAR STENTS MARKET, BY MODE OF DELIVERY 2018-2026 ($ MILLION)
TABLE 21 NORTH AMERICA VASCULAR STENTS MARKET IN BALLOON-EXPANDABLE STENTS 2018-2026 ($ MILLION)
TABLE 22 NORTH AMERICA VASCULAR STENTS MARKET IN SELF-EXPANDING STENTS 2018-2026 ($ MILLION)
TABLE 23 NORTH AMERICA VASCULAR STENTS MARKET, BY MATERIALS 2018-2026 ($ MILLION)
TABLE 24 NORTH AMERICA VASCULAR STENTS MARKET IN METALLIC STENTS 2018-2026 ($ MILLION)
TABLE 25 NORTH AMERICA VASCULAR STENTS MARKET IN METALLIC STENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 26 NORTH AMERICA METALLIC STENTS MARKET IN COBALT CHROMIUM 2018-2026 ($ MILLION)
TABLE 27 NORTH AMERICA METALLIC STENTS MARKET IN PLATINUM CHROMIUM 2018-2026 ($ MILLION)
TABLE 28 NORTH AMERICA METALLIC STENTS MARKET IN NICKEL TITANIUM 2018-2026 ($ MILLION)
TABLE 29 NORTH AMERICA METALLIC STENTS MARKET IN STAINLESS STEEL 2018-2026 ($ MILLION)
TABLE 30 NORTH AMERICA VASCULAR STENTS MARKET IN OTHER MATERIAL 2018-2026 ($ MILLION)
TABLE 31 NORTH AMERICA VASCULAR STENTS MARKET, BY END USERS 2018-2026 ($ MILLION)
TABLE 32 NORTH AMERICA VASCULAR STENTS MARKET IN HOSPITALS AND CARDIAC CENTERS 2018-2026 ($ MILLION)
TABLE 33 NORTH AMERICA VASCULAR STENTS MARKET IN HOSPITALS AND CARDIAC CENTERS 2018-2026 ($ MILLION)
TABLE 34 NORTH AMERICA VASCULAR STENTS MARKET IN AMBULATORY SURGICAL CENTERS 2018-2026 ($ MILLION)
TABLE 35 NORTH AMERICA VASCULAR STENTS MARKET, 2018-2026 ($ MILLION)
TABLE 36 NORTH AMERICA VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. RISING INCIDENCE OF CARDIOVASCULAR DISORDERS
3.2.2. ADVANCES IN STENT TECHNOLOGY
4. MARKET DETERMINANTS
4.1. MARKET DRIVERS
4.1.1. INCIDENCE OF CARDIOVASCULAR DISEASES
4.1.2. DEMAND FOR MINIMALLY INVASIVE PROCEDURES
4.1.3. ACCEPTANCE OF VASCULAR STENTS
4.1.4. FAST DEVELOPMENT IN THE GERIATRIC POPULACE
4.2. RESTRAINTS
4.2.1. DIFFICULTIES OF VASCULAR STENTS
4.2.2. PRODUCT FIASCOS AND RECALLS
4.2.3. THREAT OF ALTERNATIVES
4.3. MARKET OPPORTUNITIES
4.3.1. IMPROVEMENT OF THE STENTS ELEMENTS
4.3.2. MANDATE FROM EMERGING MARKETS IS SWELLING
4.4. MARKET CHALLENGES
4.4.1. STRINGENT REGULATORY FRAMEWORK
4.4.2. INTENSE COMPETITION
5. MARKET SEGMENTATION
5.1. MARKET BY TYPES 2018-2026
5.1.1. DRUG-ELUTING STENTS
5.1.2. BARE-METAL STENTS
5.1.3. BIOABSORBABLE STENT
5.2. MARKET BY PRODUCTS 2018-2026
5.2.1. CORONARY STENTS
5.2.2. PERIPHERAL STENTS
5.2.2.1. CAROTID ARTERY STENTS
5.2.2.2. RENAL ARTERY STENTS
5.2.2.3. FEMORAL ARTERY STENTS
5.2.2.4. OTHER PERIPHERAL STENTS
5.2.3. EVAR STENT GRAFTS
5.2.3.1. ABDOMINAL AORTIC ANEURYSM STENTS
5.2.3.2. THORACIC AORTIC ANEURYSM STENTS
5.3. MARKET BY MODE OF DELIVERY 2018-2026
5.3.1. BALLOON-EXPANDABLE STENTS
5.3.2. SELF-EXPANDING STENTS
5.4. MARKET BY MATERIALS 2018-2026
5.4.1. METALLIC STENTS
5.4.1.1. COBALT CHROMIUM
5.4.1.2. PLATINUM CHROMIUM
5.4.1.3. NICKEL TITANIUM
5.4.1.4. STAINLESS STEEL
5.4.2. OTHER MATERIAL
5.5. MARKET BY END USERS 2018-2026
5.5.1. HOSPITALS AND CARDIAC CENTERS
5.5.2. AMBULATORY SURGICAL CENTERS
6. KEY ANALYTICS
6.1. PORTERS FIVE FORCES ANALYSIS
6.1.1. BARGAINING POWER OF BUYERS
6.1.2. BARGAINING POWER OF SUPPLIERS
6.1.3. THREAT OF NEW ENTRANTS
6.1.4. THREAT OF SUBSTITUTES
6.1.5. THREAT OF RIVALRY
6.2. KEY BUYING CRITERIA
6.3. REGULATORY FRAMEWORK
6.4. VALUE CHAIN ANALYSIS
6.5. MARKET TRENDS
6.5.1. INTRODUCTION OF NEW PRODUCTS RELATED TO VASCULAR STENTS
6.5.2. HYBRID PROCEDURES ARE RISING SIGNIFICANTLY
6.5.3. TECHNOLOGY ADVANCEMENTS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
8. COMPANY PROFILES
8.1. COMPETITIVE LANDSCAPE
8.1.1. MARKET ANALYSIS
8.2. ABBOTT LABORATORIES
8.2.1. COMPANY OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. SCOT ANALYSIS
8.2.4. STRATEGIC INITIATIVE
8.3. BIOTRONIK SE & CO. KG
8.3.1. COMPANY OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. SCOT ANALYSIS
8.4. BOSTON SCIENTIFIC CORP.
8.4.1. COMPANY OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. SCOT ANALYSIS
8.4.4. STRATEGIC INITIATIVE
8.5. BRAUN MELSUNGEN AG
8.5.1. COMPANY OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. SCOT ANALYSIS
8.5.4. STRATEGIC INITIATIVE
8.6. ENDOLOGIX INC
8.6.1. COMPANY OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. SCOT ANALYSIS
8.6.4. STRATEGIC INITIATIVES
8.7. LOMBARD MEDICAL TECHNOLOGIES INC.
8.7.1. COMPANY OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. SCOT ANALYSIS
8.7.4. STRATEGIC INITIATIVES
8.8. MEDTRONIC INC.
8.8.1. COMPANY OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. SCOT ANALYSIS
8.8.4. STRATEGIC INITIATIVE
8.9. MERIL LIFE SCIENCES PRIVATE LIMITED
8.9.1. COMPANY OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.10. MICROPORT SCIENTIFIC CORPORATION
8.10.1. COMPANY OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. SCOT ANALYSIS
8.10.4. STRATEGIC INITIATIVE
8.11. TERUMO CORPORATION
8.11.1. COMPANY OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. SCOT ANALYSIS
8.11.4. STRATEGIC INITIATIVE
8.12. TRANSLUMINA GMBH
8.12.1. COMPANY OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. SCOT ANALYSIS
8.13. VASCULAR CONCEPTS LIMITED (INDIA)
8.13.1. COMPANY OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. SCOT ANALYSIS
8.14. W.L. GORE AND ASSOCIATES, INC. (U.S.)
8.14.1. COMPANY OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. SCOT ANALYSIS
8.14.4. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 NORTH AMERICA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
TABLE 2 BENEFITS OF MINIMALLY INVASIVE SURGERY
TABLE 3 NORTH AMERICA VASCULAR STENTS MARKET, BY TYPE 2018-2026 ($ MILLION)
TABLE 4 NORTH AMERICA VASCULAR STENTS MARKET IN DRUG-ELUTING STENTS 2018-2026 ($ MILLION)
TABLE 5 NORTH AMERICA VASCULAR STENTS MARKET IN BARE-METAL STENTS 2018-2026 ($ MILLION)
TABLE 6 NORTH AMERICA VASCULAR STENTS MARKET IN BIOABSORBABLE STENT 2018-2026 ($ MILLION)
TABLE 7 NORTH AMERICA VASCULAR STENTS MARKET, BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 8 NORTH AMERICA VASCULAR STENTS MARKET IN CORONARY STENTS 2018-2026 ($ MILLION)
TABLE 9 NORTH AMERICA VASCULAR STENTS MARKET IN CORONARY STENTS 2018-2026 ($ MILLION)
TABLE 10 NORTH AMERICA VASCULAR STENTS MARKET IN PERIPHERAL STENTS 2018-2026 ($ MILLION)
TABLE 11 NORTH AMERICA VASCULAR STENTS MARKET IN PERIPHERAL STENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 12 NORTH AMERICA PERIPHERAL STENTS MARKET IN CAROTID ARTERY STENTS 2018-2026 ($ MILLION)
TABLE 13 NORTH AMERICA PERIPHERAL STENTS MARKET IN RENAL ARTERY STENTS 2018-2026 ($ MILLION)
TABLE 14 NORTH AMERICA PERIPHERAL STENTS MARKET IN FEMORAL ARTERY STENTS 2018-2026 ($ MILLION)
TABLE 15 NORTH AMERICA PERIPHERAL STENTS MARKET IN OTHER PERIPHERAL STENTS 2018-2026 ($ MILLION)
TABLE 16 NORTH AMERICA VASCULAR STENTS MARKET IN EVAR STENT GRAFTS 2018-2026 ($ MILLION)
TABLE 17 NORTH AMERICA VASCULAR STENTS MARKET IN EVAR STENT GRAFTS BY TYPES 2018-2026 ($ MILLION)
TABLE 18 NORTH AMERICA EVAR STENT GRAFTS MARKET IN ABDOMINAL AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
TABLE 19 NORTH AMERICA EVAR STENT GRAFTS MARKET IN THORACIC AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
TABLE 20 NORTH AMERICA VASCULAR STENTS MARKET, BY MODE OF DELIVERY 2018-2026 ($ MILLION)
TABLE 21 NORTH AMERICA VASCULAR STENTS MARKET IN BALLOON-EXPANDABLE STENTS 2018-2026 ($ MILLION)
TABLE 22 NORTH AMERICA VASCULAR STENTS MARKET IN SELF-EXPANDING STENTS 2018-2026 ($ MILLION)
TABLE 23 NORTH AMERICA VASCULAR STENTS MARKET, BY MATERIALS 2018-2026 ($ MILLION)
TABLE 24 NORTH AMERICA VASCULAR STENTS MARKET IN METALLIC STENTS 2018-2026 ($ MILLION)
TABLE 25 NORTH AMERICA VASCULAR STENTS MARKET IN METALLIC STENTS BY TYPES 2018-2026 ($ MILLION)
TABLE 26 NORTH AMERICA METALLIC STENTS MARKET IN COBALT CHROMIUM 2018-2026 ($ MILLION)
TABLE 27 NORTH AMERICA METALLIC STENTS MARKET IN PLATINUM CHROMIUM 2018-2026 ($ MILLION)
TABLE 28 NORTH AMERICA METALLIC STENTS MARKET IN NICKEL TITANIUM 2018-2026 ($ MILLION)
TABLE 29 NORTH AMERICA METALLIC STENTS MARKET IN STAINLESS STEEL 2018-2026 ($ MILLION)
TABLE 30 NORTH AMERICA VASCULAR STENTS MARKET IN OTHER MATERIAL 2018-2026 ($ MILLION)
TABLE 31 NORTH AMERICA VASCULAR STENTS MARKET, BY END USERS 2018-2026 ($ MILLION)
TABLE 32 NORTH AMERICA VASCULAR STENTS MARKET IN HOSPITALS AND CARDIAC CENTERS 2018-2026 ($ MILLION)
TABLE 33 NORTH AMERICA VASCULAR STENTS MARKET IN HOSPITALS AND CARDIAC CENTERS 2018-2026 ($ MILLION)
TABLE 34 NORTH AMERICA VASCULAR STENTS MARKET IN AMBULATORY SURGICAL CENTERS 2018-2026 ($ MILLION)
TABLE 35 NORTH AMERICA VASCULAR STENTS MARKET, 2018-2026 ($ MILLION)
TABLE 36 NORTH AMERICA VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURES LIST
FIGURE 1 NORTH AMERICA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 2 HEART DISEASE DEATHS IN AMERICA 2017 (%)
FIGURE 3 NORTH AMERICA VASCULAR STENTS MARKET IN DRUG-ELUTING STENTS 2018-2026 ($ MILLION)
FIGURE 4 NORTH AMERICA VASCULAR STENTS MARKET IN BARE-METAL STENTS 2018-2026 ($ MILLION)
FIGURE 5 NORTH AMERICA VASCULAR STENTS MARKET IN BIOABSORBABLE STENT 2018-2026 ($ MILLION)
FIGURE 6 NORTH AMERICA VASCULAR STENTS MARKET IN PERIPHERAL STENTS 2018-2026 ($ MILLION)
FIGURE 7 NORTH AMERICA PERIPHERAL STENTS MARKET IN CAROTID ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 8 NORTH AMERICA PERIPHERAL STENTS MARKET IN RENAL ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 9 NORTH AMERICA PERIPHERAL STENTS MARKET IN FEMORAL ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 10 NORTH AMERICA PERIPHERAL STENTS MARKET IN OTHER PERIPHERAL STENTS 2018-2026 ($ MILLION)
FIGURE 11 NORTH AMERICA EVAR STENT GRAFTS MARKET IN ABDOMINAL AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
FIGURE 12 NORTH AMERICA EVAR STENT GRAFTS MARKET IN THORACIC AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
FIGURE 13 NORTH AMERICA VASCULAR STENTS MARKET IN BALLOON-EXPANDABLE STENTS 2018-2026 ($ MILLION)
FIGURE 14 NORTH AMERICA VASCULAR STENTS MARKET IN SELF-EXPANDING STENTS 2018-2026 ($ MILLION)
FIGURE 15 NORTH AMERICA VASCULAR STENTS MARKET IN METALLIC STENTS 2018-2026 ($ MILLION)
FIGURE 16 NORTH AMERICA METALLIC STENTS MARKET IN COBALT CHROMIUM 2018-2026 ($ MILLION)
FIGURE 17 NORTH AMERICA METALLIC STENTS MARKET IN PLATINUM CHROMIUM 2018-2026 ($ MILLION)
FIGURE 18 NORTH AMERICA METALLIC STENTS MARKET IN NICKEL TITANIUM 2018-2026 ($ MILLION)
FIGURE 19 NORTH AMERICA METALLIC STENTS MARKET IN STAINLESS STEEL 2018-2026 ($ MILLION)
FIGURE 20 NORTH AMERICA VASCULAR STENTS MARKET IN OTHER MATERIAL 2018-2026 ($ MILLION)
FIGURE 21 NORTH AMERICA VASCULAR STENTS MARKET IN AMBULATORY SURGICAL CENTERS 2018-2026 ($ MILLION)
FIGURE 22 NORTH AMERICA VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 23 UNITED STATES VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 24 CANADA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
COMPANIES MENTIONED
2. ABBOTT LABORATORIES
3. BIOTRONIK SE & CO. KG
4. BOSTON SCIENTIFIC CORP.
5. BRAUN MELSUNGEN AG
6. ENDOLOGIX INC
7. LOMBARD MEDICAL TECHNOLOGIES INC.
8. MEDTRONIC INC.
9. MERIL LIFE SCIENCES PRIVATE LIMITED
10. MICROPORT SCIENTIFIC CORPORATION
11. TERUMO CORPORATION
12. TRANSLUMINA GMBH
13. VASCULAR CONCEPTS LIMITED (INDIA)
14. W.L. GORE AND ASSOCIATES, INC. (U.S.)
FIGURE 1 NORTH AMERICA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 2 HEART DISEASE DEATHS IN AMERICA 2017 (%)
FIGURE 3 NORTH AMERICA VASCULAR STENTS MARKET IN DRUG-ELUTING STENTS 2018-2026 ($ MILLION)
FIGURE 4 NORTH AMERICA VASCULAR STENTS MARKET IN BARE-METAL STENTS 2018-2026 ($ MILLION)
FIGURE 5 NORTH AMERICA VASCULAR STENTS MARKET IN BIOABSORBABLE STENT 2018-2026 ($ MILLION)
FIGURE 6 NORTH AMERICA VASCULAR STENTS MARKET IN PERIPHERAL STENTS 2018-2026 ($ MILLION)
FIGURE 7 NORTH AMERICA PERIPHERAL STENTS MARKET IN CAROTID ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 8 NORTH AMERICA PERIPHERAL STENTS MARKET IN RENAL ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 9 NORTH AMERICA PERIPHERAL STENTS MARKET IN FEMORAL ARTERY STENTS 2018-2026 ($ MILLION)
FIGURE 10 NORTH AMERICA PERIPHERAL STENTS MARKET IN OTHER PERIPHERAL STENTS 2018-2026 ($ MILLION)
FIGURE 11 NORTH AMERICA EVAR STENT GRAFTS MARKET IN ABDOMINAL AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
FIGURE 12 NORTH AMERICA EVAR STENT GRAFTS MARKET IN THORACIC AORTIC ANEURYSM STENTS 2018-2026 ($ MILLION)
FIGURE 13 NORTH AMERICA VASCULAR STENTS MARKET IN BALLOON-EXPANDABLE STENTS 2018-2026 ($ MILLION)
FIGURE 14 NORTH AMERICA VASCULAR STENTS MARKET IN SELF-EXPANDING STENTS 2018-2026 ($ MILLION)
FIGURE 15 NORTH AMERICA VASCULAR STENTS MARKET IN METALLIC STENTS 2018-2026 ($ MILLION)
FIGURE 16 NORTH AMERICA METALLIC STENTS MARKET IN COBALT CHROMIUM 2018-2026 ($ MILLION)
FIGURE 17 NORTH AMERICA METALLIC STENTS MARKET IN PLATINUM CHROMIUM 2018-2026 ($ MILLION)
FIGURE 18 NORTH AMERICA METALLIC STENTS MARKET IN NICKEL TITANIUM 2018-2026 ($ MILLION)
FIGURE 19 NORTH AMERICA METALLIC STENTS MARKET IN STAINLESS STEEL 2018-2026 ($ MILLION)
FIGURE 20 NORTH AMERICA VASCULAR STENTS MARKET IN OTHER MATERIAL 2018-2026 ($ MILLION)
FIGURE 21 NORTH AMERICA VASCULAR STENTS MARKET IN AMBULATORY SURGICAL CENTERS 2018-2026 ($ MILLION)
FIGURE 22 NORTH AMERICA VASCULAR STENTS MARKET, BY COUNTRIES 2018-2026 ($ MILLION)
FIGURE 23 UNITED STATES VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
FIGURE 24 CANADA VASCULAR STENTS MARKET 2018-2026 ($ MILLION)
COMPANIES MENTIONED
2. ABBOTT LABORATORIES
3. BIOTRONIK SE & CO. KG
4. BOSTON SCIENTIFIC CORP.
5. BRAUN MELSUNGEN AG
6. ENDOLOGIX INC
7. LOMBARD MEDICAL TECHNOLOGIES INC.
8. MEDTRONIC INC.
9. MERIL LIFE SCIENCES PRIVATE LIMITED
10. MICROPORT SCIENTIFIC CORPORATION
11. TERUMO CORPORATION
12. TRANSLUMINA GMBH
13. VASCULAR CONCEPTS LIMITED (INDIA)
14. W.L. GORE AND ASSOCIATES, INC. (U.S.)
